4.7 Article

Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 222, Issue 9, Pages 1462-1467

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiaa507

Keywords

SARS-Cov-2; inactivation; temperature; detergents; methanol; paraformaldehyde; Trizol

Funding

  1. Liverpool School of Tropical Medicine Director's Catalyst Fund Award
  2. Biotechnology and Biological Sciences Research Council [BB/T001240/1, BB/S0011980/1]
  3. Royal Society Wolfson Fellowship [RSWF\R1\180013]
  4. National Institutes of Health [R21AI138074, R21AI129507]
  5. UK Research and Innovation [20197]
  6. National Institute for Health Research [NIHR2000907]
  7. Medical Research Council Developmental Pathway Funding Scheme [MR/R015406/1]
  8. Wellcome [205228/Z/16/Z]
  9. DogsTrust
  10. Wellcome Trust [205228/Z/16/Z] Funding Source: Wellcome Trust
  11. BBSRC [BB/T001240/1] Funding Source: UKRI
  12. MRC [MR/R015406/1, MR/V033441/1] Funding Source: UKRI

Ask authors/readers for more resources

The scientific community has responded to the coronavirus disease 2019 (COVID-19) pandemic by rapidly undertaking research to find effective strategies to reduce the burden of this disease. Encouragingly, researchers from a diverse array of fields are collectively working towards this goal. Research with infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is undertaken in high-containment laboratories; however, it is often desirable to work with samples at lower-containment levels. To facilitate the transfer of infectious samples from high-containment laboratories, we have tested methods commonly used to inactivate virus and prepare the sample for additional experiments. Incubation at 80 degrees C, a range of detergents, Trizol reagents, and UV energies were successful at inactivating a high titer of SARS-CoV-2. Methanol and paraformaldehyde incubation of infected cells also inactivated the virus. These protocols can provide a framework for in-house inactivation of SARS-CoV-2 in other laboratories, ensuring the safe use of samples in lower-containment levels.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available